Comparison of Intermittent vs. Continuous Walking in MS

NCT ID: NCT02726373

Last Updated: 2016-04-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective: To compare effects of an intermittent and continuous walking program on walking endurance and fatigue in people with multiple sclerosis (MS).A randomized crossover prospective method was used.The intervention consisted of eight 6-minute-long walks (2x/week for 4 weeks). The continuous condition consisted of 6 continuous minutes of walking. The intermittent condition consisted of three 2-minute bouts with 2-minute rests. After a 4-week detraining period, participants performed the second training condition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis, Endurance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intermittent walking training

Group Type EXPERIMENTAL

type of walking

Intervention Type OTHER

Subjects walked either intermittently or continuously twice a week for 4 weeks, then crossed over

Continuous Walking Training

Group Type ACTIVE_COMPARATOR

type of walking

Intervention Type OTHER

Subjects walked either intermittently or continuously twice a week for 4 weeks, then crossed over

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

type of walking

Subjects walked either intermittently or continuously twice a week for 4 weeks, then crossed over

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Positive diagnosis of MS
* Ambulatory for at least 6 minutes with or without an assistive device (e.g. cane, crutches or orthotics)
* Ability to read, understand, and sign an informed consent form

Exclusion Criteria

* Evidence of exacerbation in the prior three months as defined by a treating physician
* Orthopedic or cardiovascular condition that would interfere with ability to walk for 6 continuous minutes,
* Currently being on an active physical rehabilitation program
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hunter College of City University of New York

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Herb Karpatkin

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

INTCON1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

At-Home Gait Assessment
NCT05724901 COMPLETED